Summary
This study of risk factors for diabetic nephropathy in juvenile Type 1 (insulin-dependent) diabetes mellitus compares two carefully characterised groups of patients, one with proteinuria (n = 23), the other a control group (n = 24) with no evidence of nephropathy despite more than 25 years of diabetic life. No significant difference was observed between the groups in any HLA-A, -B or -DR antigen or Bf allotype. DR3 was present in 87% of patients with proteinuria and 75% of the diabetic control group; DR4 was present in 48% of patients with proteinuria and 63% of diabetic controls; BfFl was present in 17% of patients with nephropathy and 9% of the diabetic control group. Compared with the control group, patients with proteinuria had significantly higher mean diabetic-clinic blood glucose concentrations before the diagnosis of microvascular disease, a significantly earlier age at diagnosis of diabetes, and had more often been treated with once-daily as opposed to twice-daily insulin regimens. Susceptibility to nephropathy in Type 1 diabetes appears to be determined by the quality of metabolic control and age of onset of diabetes; although the number of subjects studied was relatively small no evidence was found of any influence of HLA or Bf phenotype.
Article PDF
Similar content being viewed by others
References
Balodimos MC (1971) Diabetic nephropathy. In: Marble A, White P, Bradley RF, Krall LP (eds) Joslin's diabetes mellitus. Lea & Febiger, Philadelphia, pp 526–561
Oakley WG, Pyke DA, Tattersall RB, Watkins PJ (1974) Long-term diabetes; a clinical study of 92 patients after 40 years. Q J Med 43: 145–156
Paz-Guevara AT, Hsu TH, White P (1975) Juvenile diabetes after 40 years. Diabetes 24: 559–565
Pirart J (1978) Diabetes mellitus and its degenerative complications; a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188, 256–263
Deckert T, Poulsen JE (1981) Diabetic nephropathy; fault or destiny? Diabetologia 21: 178–183
Cudworth AG, Bottazzo GF, Doniach D (1980) Genetic and immunological factors in Typel diabetes. In: Irvine J (ed) The immunology of diabetes. Teviot Scientific Publications, Edinburgh, pp 67–99
Bertrams J, Dewald G, Spitznas M, Rittner C (1980) HLA-A, -B, -C, -DR, Bf and C2 alleles in insulin-dependent diabetes mellitus with proliferative retinopathy. Immunobiology 158: 113–118
Dornan TL, Ting A, McPherson CK, Peckar CO, Mann JI, Turner RC, Morris P (1982) Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics. Diabetes 31: 226–231
Bodansky HJ, Wolf E, Cudworth AG, Dean BM, Nineham LJ, Bottazzo GF, Matthews JA, Kurtz AB, Kohner EM (1982) Genetic and immunologic factors in microvascular disease in Type 1 insulin-dependent diabetes. Diabetes 31: 70–74
Klouda PT, Manos J, Acheson EJ, Dyer PA, Goldby FS, Harris R, Lawler W, Mallick NP, Williams G (1979) Strong association between idiopathic membranous nephropathy and HLA-DRw3. Lancet 2: 770–771
Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ (1980) HLA-DR antigens and toxic reaction to sodium auriothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med 303: 300–302
Danilovs JA, Ayoub G, Terasaki PI (1980) B lymphocyte isolation by thrombin-nylon wool. In: Terasaki PI (ed) Histocompatibility testing. UCLA Press, Los Angeles, pp 287–288
Varley H, Gowenlock AH, Bell M (1980) Practical clinical biochemistry, Vol 1, 5th edn. Heinemann, London
Jervell J, Solheim B (1979) HLA antigens in long-standing insulin-dependent diabetics with terminal nephropathy and retinopathy with and without loss of vision. Diabetologia 17: 391 (Letter)
Barbosa J, Noreen H, Goetz F, Simmons R, de Leiva A, Najarian J, Yunis E (1976) Histocompatibility antigens and diabetic microangiopathy. Tissue Antigens 7: 233–237
Barbosa J (1981) Is diabetic microangiopathy genetically heterogenous? HLA and diabetic nephropathy. Horm Metab Res (Suppl) 11: 77–80
Burditt AF, Caird FI, Draper GJ (1968) The natural history of diabetic retinopathy. Q J Med 37: 303–317
Dornan T, Mann JI, Turner RC (1982) Factors protective against retinopathy in insulin-dependent diabetics free of retinopathy for 30 years. Br Med J 285: 1073–1077
Cudworth AG, Bodansky HJ (1982) Genetic and metabolic factors in relation to the prevalence and severity of diabetic complications. In: Keen H, Jarrett J (eds) Complications of diabetes, 2nd edn. Edward Arnold, London, pp 1–18
Deckert T, Andersen AR, Christiansen JS, Andersen JK (1981) The course of diabetic nephropathy. Factors related to development. Acta Endocrinol (Copenh) Suppl 242: 14–15
Bottazzo GF, Cudworth AG, Moul DJ, Doniach D, Festenstein H (1978) Evidence for a primary autoimmune type of diabetes. Br Med J 2: 1253–1255
Platz P, Jakobsen BK, Morling N, Ryder LP, Svejgaard A, Thomsen M, Christy M, Kromann H, Benn J, Nerup J, Green A, Hauge M (1981) HLA-D and DR antigens in genetic analysis of insulin-dependent diabetes. Diabetologia 21: 108–115
Tchobroutsky G, Charitanski D, Blouquit Y, Papoz L, Soria J, Rosa J (1980) Diabetic control in 102 insulin-treated out-patients. Diabetologia 18: 447–452
Christiansen JS, Nerup J (1978) Smoking and diabetic nephropathy. Lancet 1: 605 (Letter)
Berkmann J, Rifkin H (1973) Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson). Report of a case. Metabolism 22: 715–722
Mauer SM, Steffes MW, Azar S, Sandberg SK, Brown DM (1978) The effect of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes 27: 738–744
Viberti GC, Hill RD, Jarrett RI, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1: 1430–1432
Viberti GC, MacKintosh D, Bilous RW, Pickup JC, Keen H (1982) Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycaemia. Kidney Int 21: 714–720
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walton, C., Mallick, N.P., Oleesky, S. et al. HLA antigens and risk factors for nephropathy in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 27, 3–7 (1984). https://doi.org/10.1007/BF00253492
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00253492